01 1Hubei Biocause Heilen Pharmaceutical Co., Ltd
01 1IBUPROFEN USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-26
Pay. Date : 2013-02-06
DMF Number : 15839
Submission : 2002-01-25
Status : Active
Type : II
20
Hubei Biocause Heilen Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is IBUPROFEN USP, with a corresponding US DMF Number 15839.
Remarkably, this DMF maintains an Active status since its submission on January 25, 2002, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 26, 2013, and payment made on February 06, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
